PDCD1 and neoplasm: It is mainly expressed on the surface of activated T cells, but its ligand PD-L1 is expressed in many cell types, such as APCs, macrophages, and tumor cells, etc. Under normal circumstances, PD-1 binding of PD-L1 can stop the continuous activation of T cells and prevent the occurrence of autoimmune diseases.